相关实验视频

Updated: Jun 15, 2026

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System

Published on: April 6, 2021

有效的体外测试用于评估药物疗效和对新出现的SARS-CoV-2菌株的协同作用

Maximillian Woodall¹, Samuel Ellis¹, Shengyuan Zhang¹

¹UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Antimicrobial agents and chemotherapy

|December 17, 2024

概括

开发有效的COVID-19治疗方法需要有效查抗病毒药物组合. 这项研究提出了一种新的测定方法,以确定针对SARS-CoV-2的协同抗病毒疗法,包括新兴变种.

科学领域:

病毒学病毒学
药理学药理学是指药理学的学科.
药物发现药物发现药物发现

背景情况:

针对COVID-19存在抗病毒单一疗法,但组合可能会提供更高的疗效.
目前用于查抗病毒组合对抗呼吸道病毒的方法通常是劳动密集型的,并且不成熟.
识别有效的抗病毒组合对于对抗SARS-CoV-2至关重要,特别是在新出现的变种中.

研究的目的:

开发和验证一个时间效率高的体外药物敏感性测定,用于严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2).
评估抗病毒单一疗法和组合疗法对祖先和新出现的SARS-CoV-2菌株的疗效.
为了确定协同作用的抗病毒组合,以改善COVID-19治疗.

主要方法:

开发了一种72-96小时的体外药物敏感性测定,使用96井板检测SARS-CoV-2.
应用多种协同效应模型 (零相互作用强度,最高单一药物,Loewe,Bliss) 来评估药物疗效.
对抗各种SARS-CoV-2菌株的抗病毒药物的测试,包括remdesivir,nirmatrelvir和EIDD-1931.

主要成果:

雷梅西维尔,涅马特利维尔和EIDD-1931的单疗法显示出基线EC50s在临床上可达到的水平内对抗祖先菌株.
抗病毒疗效与Omicron变种BA.1.1.15和BA.2不同,对nirmatrelvir.vir的疗效降低.
在所有测试的SARS-CoV-2菌株中,在remdesivir和nirmatrelvir之间观察到一致和强大的协同效应.

结论:

开发的试验为简化对SARS-CoV-2有效抗病毒组合疗法的识别提供了实用工具.
针对多个病毒成分的抗病毒药物组合得到支持,以提高COVID-19治疗效率.
这些发现强调了组合疗法在克服抗病毒耐药性和应对新出现的病毒菌株方面的重要性.

关键词:

在 COVID-19 疫情中,这就是Omicron.这就是SARS-CoV-2病毒.药物协同作用药物协同作用在体外测定试验.感染感染的感染.

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

相关概念视频

Drug Product Performance: In Vitro–In Vivo Correlation

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...